Professional Documents
Culture Documents
REVIEW ARTICLE
Deutsches rzteblatt International | Dtsch Arztebl Int 2011; 108(16): 26773 267
MEDICINE
268 Deutsches rzteblatt International | Dtsch Arztebl Int 2011; 108(16): 26773
MEDICINE
During labor, the rapid rise in cardiac output, heart rate, BOX
and blood pressure may lead to pulmonary edema, par-
ticularly if the mother suffers from mitral stenosis. In
patients with obstruction of the left ventricle, the main Cardiovascular diseases that make pregnancy
risks are of diastolic heart failure and arrhythmia (12). unadvisable*
In patients with valve insufficiency and restricted left High-grade pulmonary hypertension of any origin (50% of systemic pressure)
ventricular function, this can lead to heart failure. Post-
partum, the risk of this is higher, due to the increased Severe left or right ventricular dysfunction (LV ejection fraction <40%)
venous return flow. Patients with severe heart failure (NYHA class III/IV)
Patients with heart valve defects should receive Severe left heart obstruction (aortic stenosis with average pressure gradient
detailed cardiological counseling on the risks of preg- >50 mm Hg according to Doppler ultrasound, high-grade [recurrent] aortic
nancy before becoming pregnant. An interdisciplinary isthmus stenosis)
treatment plan should be drawn up in case they become
pregnant. Severe mitral stenosis (average pressure gradient >10 mm Hg, valve aperture
area <1 cm2)
Mitral stenosis (MS) Marfan syndrome with ectasia of the aorta ascendens (45 mm)
Asymptomatic women with valve aperture area
>1.5 cm2 usually tolerate pregnancy well. If heart rate
Cyanotic heart disease (especially with oxygen saturation <80%)
or venous return flow increases postpartum, beta-1 *modified according to (3)
selective beta-blockers and diuretics can be adminis-
tered, initially at low doses (3).
In patients with moderate and severe MS (valve
aperture area <1.5 cm2), balloon valvuloplasty should
be performed before pregnancy, regardless of clinical
symptoms, as there is a risk of pulmonary edema, often
accompanied by tachyarrhythmia (3). Balloon valvulo-
plasty is the treatment of choice and even during preg-
nancy can be performed with low complication rates. mother of heart failure and cardiac arrhythmias (12).
Maternal and fetal mortality following valvuloplasty is Symptomatic patients with severe aortic stenosis and
<1% and morbidity is also low, at 2% to 4%. The most asymptomatic women with restricted left ventricular
common complication is mitral insufficiency (e4). function or a pathological stress ECG should be ad-
If there is severe calcification of the valve, a closed vised against becoming pregnant and should ideally
commissurotomy can be considered. Maternal mortal- undergo valvuloplasty or surgery before a planned
ity is <2%, and fetal mortality between 2% and 8%. pregnancy (3). If valvuloplasty cannot be performed,
With open commissurotomy or valve replacement, fetal heart valve replacement should be considered. A Ross
mortality is between 10% and 30%. operation (replacement of the aortic valve using an
Biological prostheses are favored for valve replace- autologous pulmonary valve and implantation of a
ments, although they do have the following disadvan- homograft or biological prosthesis in the pulmonary
tages: position) has the advantage, for women who wish to
High degeneration rate: between 10% and 30% have children, that no anticoagulants are required even
Reoperation rates between 30% and 50% after if the patient later becomes pregnant. However,
10 years, with because of the high reoperation risk in adults this is a
Perioperative mortality between 3% and 10% controversial procedure (15).
(13). Cardiologists should closely monitor asymptomatic
Artificial prostheses require anticoagulants even women with severe aortic stenosis not diagnosed until
during pregnancy. This requires intensive risk analysis, pregnancy, normal left ventricular function, and a nor-
due to the associated problems of coumarin embryo- mal stress ECG as part of their care. Symptomatic treat-
pathy and hemorrhaging complications (14). ment involves diuretics. In the event of heart failure,
beta-1 selective beta-blockers are also used, and re-
Aortic stenosis duced physical activity is recommended. For patients
In the industrialized world, most aortic valve stenoses who do not respond to drug treatment and for whom
in women of child-bearing age are congenital bicuspid early delivery is impossible, a valvuloplasty or valve
aortic valves. In non-industrialized countries, rheu- surgery must be performed during pregnancy (3).
matic origin is the most common.
While patients with mild and moderate aortic steno- Aortic insufficiency and mitral insufficiency
sis often tolerate pregnancy with no complications, se- Due to their reduced peripheral vascular resistance, pa-
vere aortic stenosis (valve aperture area <1.0 cm2 or tients with only moderate to severe valve insufficiency
<0.6 cm2/m2 body surface; average Doppler ultrasound tolerate pregnancy well provided their left ventricular
pressure gradient >50 mm Hg) is associated with a sig- function is normal. Patients whose main symptom is
nificantly increased risk to the fetus and risk to the shortness of breath respond well to restricted salt
Deutsches rzteblatt International | Dtsch Arztebl Int 2011; 108(16): 26773 269
MEDICINE
TABLE 1
Defect Severity NYHA class Maternal com- Neonatal com- Recommendations Recommen-
plications plications dation of
evidence
Mitral insufficiency
Mild III Rare: CA None Monitoring; med. only for symptomatic CA IC
Moderate III Slightly in- None Med. for CA IIaC
creased: CA,
rare: HF
Severe IIIIV Significantly Increased: 1, 2, Pregnancy before surgery contraindicated IC
increased: CA, 3
HF, PE, EC
Mitral stenosis
Mild I Rare: CA None Monitoring; med. only for symptomatic CA, IC
beta-blockers
Moderate II Increased: CA, Increased: 1, 2, For atrial fibrillation: anticoagulants, beta-blockers, IIaC
TE, PE, EC 3 digitalis, verapamil to control heart rate, valvulo-
plasty ideally before pregnancy, and if symptomatic
also during pregnancy
Severe IIIV Greatly in- Increased: 1, 2, No pregnancy before valvuloplasty; in pregnant IC
creased: CA, 3 women with symptoms valvuloplasty can be per-
PE, EC formed
Aortic insufficiency
Mild III None None Monitoring IC
Moderate III Rare: CA, HF Rare: 1, 2 Med. for CA and HF IIaC
Severe IIIIV Increased: CA, Increased: 1, 2 No pregnancy before surgery IC
HF, EC
Aortic stenosis
Mild I Rare: CA None Monitoring; med. only for symptomatic CA IC
Moderate II Increased: HF, Increased: 1, 2, Med. for CA and HF IIaC
CA 3
Severe IIIIV Greatly in- Increased: 1, 2, No pregnancy before intervention (valvuloplasty/ IC
creased: HF, CA, 3 surgery); bed rest during 3rd trimester of pregnan-
sudden cardiac cy; C section
death
EC: endocarditis; HF: heart failure; PE: pulmonary edema; med: medication; CA: cardiac arrhythmias, TE: thromboembolism;
Neonatal complications: 1 = intrauterine growth retardation: 2 = low birth weight: 3 = stillbirth
*modified according to (3)
intake, diuretics and digitalis. Precautionary use of latter risk is low (16, 17) and dose-dependent (18, 19).
nifedipine or hydralazine is possible if patients exhibit No embryopathy is observed with warfarin doses
hypertension. Patients with NYHA class III/IV or <5 mg, equivalent to <3 mg phenprocoumon. At higher
restricted left ventricular function are at significantly doses, the rate was 8% (18, 19).
higher risk and should undergo heart surgery, prefer- Continued oral administration of anticoagulants until
ably reconstructive, before pregnancy. the 36th week of pregnancy and a subsequent switch to
unfractionated heparin until delivery is the safest treat-
Mechanical heart valve prostheses and ment for the mother (14). Anticoagulation using
anticoagulants low-molecular weight heparin in the first trimester is
Hemodynamically, patients with mechanical heart only justified when regular monitoring of anti-factor
valves tolerate pregnancy well provided their left ven- Xa activity (1.01.2 U/L) is guaranteed and high doses
tricular function is not restricted and they do not suffer of phenprocoumon are required (3, 7). If anticoagu-
from pulmonary hypertension. lation is inadequate during pregnancy, the mother is at
The necessary oral anticoagulants are associated high risk of valve thrombosis and thromboembolism.
with an increased risk of hemorrhage and a risk of cou- An overview of current anticoagulation medication is
marin embryopathy; recent studies have shown that the provided in Table 2 (14).
270 Deutsches rzteblatt International | Dtsch Arztebl Int 2011; 108(16): 26773
XXXXX
MEDICINE
TABLE 2
BM: breastmilk; MHVR: mechanical heart valve replacement; LMP: last menstrual period; ASA, acetylsalicylic acid; HIT, heparin-induced thrombocytopenia
Deutsches rzteblatt International | Dtsch Arztebl Int 2011; 108(16): 26773 271
MEDICINE
272 Deutsches rzteblatt International | Dtsch Arztebl Int 2011; 108(16): 26773
MEDICINE
10. Siu SC, Sermer M, Harrison DA, et al.: Risk and predictors for 19. Cotrufo M, De Feo M, De Santo LS, et al.: Risk of warfarin during
pregnancy-related complications in women with heart disease. pregnancy with mechanical valve prostheses. Obstet Gynecol 2002;
Circulation 1997; 96: 278994. 99: 3540.
11. Gesundheitsberichterstattung. Krankenhausstatistik-Diagnosedaten 20. Hall R, Olivier GJ, Rossouw D, Grove AF, Doubell D: Pregnancy out-
ICD10 angeborene und erworbene Aorten -und Mitralklappenerk- come in women with prosthetic heart valves. J Obstet Gynaecol
rankungen bei Frauen In: Statistisches Bundesamt, Robert Koch-In- 2001; 21: 14953.
stitut Berlin; 2008. 21. Gesundheitsberichterstattung. MONICA/KORA Herzinfarktregister
12. Yap SC, Drenthen W, Pieper PG, et al.: Risk of complications during Augsburg: Letalitt des Myokardinfarkt. In: Statistisches Bundes-
pregnancy in women with congenital aortic stenosis. Int J Cardiol amt, Robert Koch -Institut Berlin; 19872007.
2008; 126: 2406. 22. Wilson AM, Boyle AJ, Fox P: Management of ischaemic heart dis-
13. Weiss BM, von Segesser LK, Alon E, Seifert B, Turina MI: Outcome ease in women of child-bearing age. Intern Med J 2004; 34:
of cardiovascular surgery and pregnancy: a systematic review of 6947.
the period 19841996. Am J Obstet Gynecol 1998; 179: 23. Bac DJ, Lotgering FK, Verkaaik AP, Deckers JW: Spontaneous cor-
164353. onary artery dissection during pregnancy and post partum. Eur
14. Gohlke-Brwolf C, Pildner von Steinburg S, Kaemmerer H, Regitz- Heart J 1995; 16: 1368.
Zagrosek V: Antikoagulation und Gerinnungsstrungen in der 24. Edison RJ, Muenke M: Central nervous system and limb anomalies
Schwangerschaft. Internist 2008; 49: 77987. in case reports of first-trimester statin exposure. N Engl J Med
15. Klieverik LM, Takkenberg JJ, Bekkers JA, Roos-Hesselink JW, Wit- 2004; 350: 157982.
senburg M, Bogers AJ: The Ross operation: a Trojan horse? Eur 25. Johnson LW, Moore RJ, Balter S: Review of radiation safety in the
Heart J 2007; 28:1993-2000. cardiac catheterization laboratory. Cathet Cardiovasc Diagn 1992;
16. Schaefer C, Hannemann D, Meister R, et al.: Vitamin K antagonists 25: 18694.
and pregnancy outcome. A multi-centre prospective study. Thromb
Haemost 2006; 95: 94957. Corresponding author
Prof. Dr. med. Vera Regitz-Zagrosek
17. van Driel D, Wesseling J, Sauer PJ, Touwen BC, van der Veer E, Institut fr Geschlechterforschung in der Medizin und
Heymans HS: Teratogen update: fetal effects after in utero exposure Center for Cardiovascular Research
to coumarins overview of cases, follow-up findings, and patho- Charit Universittsmedizin, Hessische Str. 34
genesis. Teratology 2002; 66: 12740. 10115 Berlin, Germany
Vera.Regitz-Zagrosek@charite.de
18. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M:
Dose-dependent fetal complications of warfarin in pregnant women
with mechanical heart valves. J Am Coll Cardiol 1999; 33:
163741. @ For eReferences please refer to:
www.aerzteblatt-international.de/ref1611
Deutsches rzteblatt International | Dtsch Arztebl Int 2011; 108(16): 26773 273
MEDICINE
REVIEW ARTICLE
eReferences
e1. Kaemmerer H, Hess J: Congenital heart disease. Transition from
adolescence to adulthood. Internist 2009; 50:12212, 12247.
e2. Hilfiker-Kleiner D, Schieffer E, Meyer GP, Podewski E, Drexler H:
Postpartum cardiomyopathy: a cardiac emergency for gynecol-
ogists, general practitioners, internists, pulmonologists, and car-
diologists. Dtsch Arztebl Int 2008; 105:7516.
e3. Geva T, Mauer MB, Striker L, Kirshon B, Pivarnik JM: Effects of
physiologic load of pregnancy on left ventricular contractility and
remodeling. Am Heart J 1997; 133:539.
e4. Sivadasanpillai H, Srinivasan A, Sivasubramoniam S, et al.: Long-
term outcome of patients undergoing balloon mitral valvotomy in
pregnancy. Am J Cardiol 2005; 95:15046.
e5. Montoya ME, Karnath BM, Ahmad M: Endocarditis during preg-
nancy. South Med J 2003; 96:11567.
e6. Avila WS, Rossi EG, Ramires JA, et al.: Pregnancy in patients with
heart disease: experience with 1 000 cases. Clin Cardiol 2003;
26:13542.
e7. Schaefer C, Spielmann H, Vetter K: Arzneiverordnung in Schwan-
gerschaft und Stillzeit. Mnchen: Urban & Fischer 2006.
e8. Hartel D, Sorges E, Carlsson J, Romer V, Tebbe U: Myocardial in-
farction and thromboembolism during pregnancy. Herz 2003
28:17584.
e9. Roth A, Elkayam U: Acute myocardial infarction associated with
pregnancy. J Am Coll Cardiol 2008; 52:17180.
e10. Hennekens CH: Risk factors for coronary heart disease in women.
Cardiol Clin 1998; 16:18.
I Deutsches rzteblatt International | Dtsch Arztebl Int 2011; 108(16) | Regitz-Zagrosek et al.: eReferences